Use of Selective Serotonin Reuptake Inhibitors and Risk of Upper Gastrointestinal Tract Bleeding | Zendy

Susanne Oksbjerg Dalton | Zendy; Christoffer Johansen | Zendy; Lene Mellemkjær | Zendy; Henrik Toft Sørensen | Zendy; Bente Mertz Nørgård | Zendy; Jørgen H. Olsen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Use of Selective Serotonin Reuptake Inhibitors and Risk of Upper Gastrointestinal Tract Bleeding

Author(s) -

Susanne Oksbjerg Dalton,

Christoffer Johansen,

Lene Mellemkjær,

Henrik Toft Sørensen,

Bente Mertz Nørgård,

Jørgen H. Olsen

Publication year - 2003

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.163.1.59

Subject(s) - upper gastrointestinal bleeding , medicine , confidence interval , aspirin , antidepressant , relative risk , serotonin reuptake inhibitor , reuptake inhibitor , population , medical prescription , serotonin , anesthesia , pharmacology , endoscopy , environmental health , hippocampus , receptor

Selective serotonin reuptake inhibitors (SSRIs) have been suspected of increasing the risk of bleeding. We examined the risk of upper gastrointestinal tract (GI) bleeding with use of antidepressant medication.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research